Studies have shown involvement of these miRs in key cancer signal transduction pathways: miR-221 in the KRAS pathway, miR -92a in EGFR activation and miR -21 in TGF-β signaling (Sebio et al., 2013; Shirafkan et al., 2018). This evidence concerns the gene EGFR and cancer.